4,835 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Westbourne Investments Inc.

Westbourne Investments Inc. purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 4,835 shares of the medical equipment provider’s stock, valued at approximately $2,524,000. Intuitive Surgical makes up 1.5% of Westbourne Investments Inc.’s holdings, making the stock its 17th largest holding.

A number of other institutional investors have also modified their holdings of ISRG. Vanguard Group Inc. lifted its stake in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the period. Geode Capital Management LLC grew its holdings in shares of Intuitive Surgical by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after purchasing an additional 243,802 shares during the period. Fisher Asset Management LLC raised its position in shares of Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after buying an additional 86,488 shares during the period. Norges Bank purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $2,401,493,000. Finally, Invesco Ltd. increased its holdings in Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock valued at $2,165,184,000 after purchasing an additional 295,025 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Up 0.2 %

Intuitive Surgical stock opened at $515.80 on Thursday. The firm’s fifty day moving average price is $506.68 and its two-hundred day moving average price is $533.01. Intuitive Surgical, Inc. has a 1-year low of $367.39 and a 1-year high of $616.00. The firm has a market capitalization of $184.87 billion, a price-to-earnings ratio of 80.47, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the company posted $1.50 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on ISRG shares. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Royal Bank of Canada decreased their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $598.95.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,695,113.84. This trade represents a 3.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,913 shares of company stock worth $15,981,143 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.